POINT (PentOxifylline In Necrotising enTerocolitis)

Safety and efficacy of pentoxifylline as a treatment for preventing the progression of necrotising enterocolitis in preterm neonates - A randomised, placebo controlled trial (Pilot phase)

Australian Clinical Trials Registry (ACTR): ACTRN012606000257561

Principal Investigator:
Dr Sanjay Patole
Ph: + 61 8 9340 1260
Fax: +61 8 9340 1266
Email:
Sanjay.Patole@health.wa.gov.au

Co-Investigators:
Dr Peter Richmond
Professor Karen Simmer
Dr Dorota Doherty (biostatistician)

Study coordinators:
Dr Jackie Gardiner / Ms Jo Blacker

Coordinating Centre:
Department of Neonatal Paediatrics,
King Edward Memorial Hospital for Women, Perth. Western Australia